Annika Wahlström

7.7k total citations · 3 hit papers
36 papers, 5.4k citations indexed

About

Annika Wahlström is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Annika Wahlström has authored 36 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 18 papers in Surgery and 14 papers in Molecular Biology. Recurrent topics in Annika Wahlström's work include Drug Transport and Resistance Mechanisms (25 papers), Pediatric Hepatobiliary Diseases and Treatments (14 papers) and Liver Disease Diagnosis and Treatment (10 papers). Annika Wahlström is often cited by papers focused on Drug Transport and Resistance Mechanisms (25 papers), Pediatric Hepatobiliary Diseases and Treatments (14 papers) and Liver Disease Diagnosis and Treatment (10 papers). Annika Wahlström collaborates with scholars based in Sweden, Austria and Netherlands. Annika Wahlström's co-authors include Hanns–Ulrich Marschall, Fredrik Bäckhed, Sama I. Sayin, Bo Angelin, Tuulia Hyötyläinen, Matej Orešič, Sirkku Jäntti, Krister Bamberg, Antonio Molinaro and Marcus Ståhlman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Annika Wahlström

34 papers receiving 5.3k citations

Hit Papers

Intestinal Crosstalk between Bile Acids and Microbiota an... 2013 2026 2017 2021 2016 2013 2017 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annika Wahlström Sweden 23 3.1k 1.7k 1.5k 1.4k 1.3k 36 5.4k
Sama I. Sayin Sweden 4 2.4k 0.8× 1.1k 0.6× 1.0k 0.7× 1.2k 0.8× 829 0.6× 9 3.8k
Waddah A. Alrefai United States 38 2.2k 0.7× 1.1k 0.6× 709 0.5× 647 0.5× 1.3k 1.0× 149 4.7k
William M. Pandak United States 51 3.1k 1.0× 2.4k 1.4× 2.3k 1.6× 677 0.5× 2.7k 2.1× 123 7.1k
Jason M. Ridlon United States 33 5.2k 1.7× 2.0k 1.1× 2.3k 1.6× 1.8k 1.3× 1.5k 1.2× 66 8.3k
Lixin Zhu China 37 3.3k 1.1× 581 0.3× 2.5k 1.7× 1.5k 1.0× 755 0.6× 129 6.0k
Timon E. Adolph Austria 32 2.6k 0.8× 570 0.3× 2.0k 1.3× 1.0k 0.7× 730 0.6× 68 5.5k
Dominique Rainteau France 35 1.8k 0.6× 682 0.4× 869 0.6× 644 0.5× 850 0.7× 105 3.7k
Xiang Zhang Hong Kong 34 2.5k 0.8× 860 0.5× 1.9k 1.3× 693 0.5× 600 0.5× 71 4.8k
Frank G. Schaap Netherlands 38 2.2k 0.7× 1.3k 0.7× 1.4k 1.0× 702 0.5× 1.7k 1.3× 108 5.2k
Francesca Romana Ponziani Italy 39 1.8k 0.6× 480 0.3× 2.1k 1.4× 882 0.6× 1.0k 0.8× 178 5.1k

Countries citing papers authored by Annika Wahlström

Since Specialization
Citations

This map shows the geographic impact of Annika Wahlström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annika Wahlström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annika Wahlström more than expected).

Fields of papers citing papers by Annika Wahlström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annika Wahlström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annika Wahlström. The network helps show where Annika Wahlström may publish in the future.

Co-authorship network of co-authors of Annika Wahlström

This figure shows the co-authorship network connecting the top 25 collaborators of Annika Wahlström. A scholar is included among the top collaborators of Annika Wahlström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annika Wahlström. Annika Wahlström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aydin, Ömrüm, Annika Wahlström, Patrick A. de Jonge, et al.. (2024). An integrated analysis of bile acid metabolism in humans with severe obesity. Hepatology. 81(1). 19–31. 2 indexed citations
2.
Wahlström, Annika, Ömrüm Aydin, Lisa Olsson, et al.. (2024). Alterations in bile acid kinetics after bariatric surgery in patients with obesity with or without type 2 diabetes. EBioMedicine. 106. 105265–105265. 9 indexed citations
3.
Ovadia, Caroline, Álvaro Perdones-Montero, Benjamin H. Mullish, et al.. (2020). Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy. Scientific Reports. 10(1). 3895–3895. 35 indexed citations
4.
Papacleovoulou, Georgia, Flavia Flaviani, Shadi Abu‐Hayyeh, et al.. (2020). Ursodeoxycholic acid improves feto-placental and offspring metabolic outcomes in hypercholanemic pregnancy. Scientific Reports. 10(1). 10361–10361. 17 indexed citations
5.
Al-Dury, Samer, Annika Wahlström, Katrin Panzitt, et al.. (2019). Obeticholic acid may increase the risk of gallstone formation in susceptible patients. Journal of Hepatology. 71(5). 986–991. 49 indexed citations
6.
Ovadia, Caroline, Álvaro Perdones-Montero, Konstantina Spagou, et al.. (2019). Enhanced Microbial Bile Acid Deconjugation and Impaired Ileal Uptake in Pregnancy Repress Intestinal Regulation of Bile Acid Synthesis. Hepatology. 70(1). 276–293. 56 indexed citations
7.
Nikolova, Vanya, Julie A. K. McDonald, Annika Wahlström, et al.. (2019). Obeticholic acid ameliorates dyslipidemia but not glucose tolerance in mouse model of gestational diabetes. American Journal of Physiology-Endocrinology and Metabolism. 317(2). E399–E410. 19 indexed citations
8.
Kovatcheva‐Datchary, Petia, Saeed Shoaie, Sunjae Lee, et al.. (2019). Simplified Intestinal Microbiota to Study Microbe-Diet-Host Interactions in a Mouse Model. Cell Reports. 26(13). 3772–3783.e6. 52 indexed citations
9.
Wahlström, Annika. (2018). Outside the liver box: The gut microbiota as pivotal modulator of liver diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(5). 912–919. 24 indexed citations
10.
Krones, Elisabeth, Kathrin Eller, Marion J. Pollheimer, et al.. (2017). NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice. Journal of Hepatology. 67(1). 110–119. 44 indexed citations
11.
Wahlström, Annika, Petia Kovatcheva‐Datchary, Marcus Ståhlman, Fredrik Bäckhed, & Hanns–Ulrich Marschall. (2017). Crosstalk between Bile Acids and Gut Microbiota and Its Impact on Farnesoid X Receptor Signalling. Digestive Diseases. 35(3). 246–250. 81 indexed citations
12.
Molinaro, Antonio, Annika Wahlström, & Hanns–Ulrich Marschall. (2017). Role of Bile Acids in Metabolic Control. Trends in Endocrinology and Metabolism. 29(1). 31–41. 330 indexed citations breakdown →
13.
Wahlström, Annika, Sama I. Sayin, Hanns–Ulrich Marschall, & Fredrik Bäckhed. (2016). Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism. Cell Metabolism. 24(1). 41–50. 1990 indexed citations breakdown →
14.
Al-Dury, Samer, et al.. (2016). CYP3A11 is Dispensable for the Formation of Murine Bile Acids. Journal of Hepatology. 64(2). S436–S436.
15.
Baghdasaryan, Anna, Claudia Fuchs, Christoph H. Österreicher, et al.. (2015). Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis. Journal of Hepatology. 64(3). 674–681. 143 indexed citations
16.
Sayin, Sama I., Annika Wahlström, Sirkku Jäntti, et al.. (2013). Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist. Cell Metabolism. 17(2). 225–235. 1744 indexed citations breakdown →
17.
Liu, Meng, Anna-Karin Sjögren, Christin Karlsson, et al.. (2010). Targeting the protein prenyltransferases efficiently reduces tumor development in mice with K-RAS-induced lung cancer. Proceedings of the National Academy of Sciences. 107(14). 6471–6476. 86 indexed citations
18.
Bergö, Martin O., Annika Wahlström, Loren G. Fong, & Stephen G. Young. (2008). Genetic Analyses of the Role of RCE1 in RAS Membrane Association and Transformation. Methods in enzymology on CD-ROM/Methods in enzymology. 438. 367–389. 10 indexed citations
19.
Sjögren, Anna-Karin, Karin Andersson, Meng Liu, et al.. (2007). GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS–induced lung cancer. Journal of Clinical Investigation. 117(5). 1294–1304. 85 indexed citations
20.
Wahlström, Annika, Briony A. Cutts, Christin Karlsson, et al.. (2006). Rce1 deficiency accelerates the development of K-RAS–induced myeloproliferative disease. Blood. 109(2). 763–768. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026